Speaker: Hiroji Iwata

0:03:28

Professor Hiroji Iwata - 2022 Breast Cancer Trials Annual Scientific Meeting

0:09:54

「GBCC Sketch EP 04」 Meet Prof. Hiroji Iwata & Prof. Sehwan Han

0:01:00

Emerging mechanisms of resistance to endocrine therapies in HR+ breast cancer

0:05:34

NEOS: prognosis of ER+ breast cancer pts who received neoadjuvant ET with/without adjuvant chemo

0:01:30

Findings from the SCRUM Japan Genie screening projectin breast cancer

0:02:35

Use of neoadjuvant approaches in breast cancer during the COVID-19 pandemic

0:01:31

Future research directions for ER+ positive breast cancer

0:32:04

Speaker Series with Rebecca Dent - High Performance Nutrition for Ultra Running

0:01:25

Dr. Iwata Discusses DS-8201a in HER2+ Breast Cancer

0:00:46

'GBCC TV' is the official YouTube channel of Global Breast Cancer Conference (GBCC)!

0:02:39

New approach to cancer diagnosis and treatment

0:40:44

ICAHO19 - Breast cancer session: Sequencing therapies in metastatic breast cancer

0:06:47

Emerging treatments for breast cancer with brain metastases

0:02:07

Dr. Dent on Final LOTUS 2 Findings From the LOTUS 2 Trial in TNBC

0:03:55

Dr Reshma Mahtani, DO

0:00:54

Debra Patt, MD, PhD, MBA, summarizes data from the ExteNET trial presented at SABCS 2020

0:07:36

ESMO 2020 Expert Video report on atezolizumab in upfront treatment of TNBC

0:03:12

Debra Patt, MD, on how applied informatics is being incorporated into cancer patient management

0:51:41

Session 1 - Being pragmatic in the time of COVID-19: Linking a cancer diagnosis with treatment

0:16:09

Ahmad Awada: Optimizing outcome and benefit/risk by tailoring adjuvant chemotherapy in early sta...

0:01:03

Debra Patt, MD, PhD, MBA, comments on findings from the KEYNOTE-355 trial

0:02:01

Dr Debra Patt Outlines Cancer Care Delivery, Payment Changes

1:04:41

WCS Webinars: Nutrition with Rebecca Dent

0:04:55

Trailblazers: Dr. Shani Paluch-Shimon